Navigation Links
Kendle to Present at 2010 Wells Fargo Securities Healthcare Conference
Date:6/17/2010

CINCINNATI, June 17 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced the Company will participate in the upcoming 2010 Wells Fargo Securities Healthcare Conference on June 23, 2010, at the InterContinental Hotel in Boston.

Kendle's formal presentation will be given by Chairman and Chief Executive Officer Candace Kendle, PharmD, at 1 p.m. Eastern Time.

The presentation will be webcast and may be accessed at www.kendle.com in the "Investors Events & Presentations" section or at www.wsw.com/webcast/wa61/kndl/

Slides will be available by 10 a.m. on the day of the presentation at www.kendle.com in the "Investors Events & Presentations" section.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the world's largest global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 500, Cincinnati, OH 45202 or from the Company's Web site at www.kendle.com.


'/>"/>
SOURCE Kendle International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kendle Advances Early Stage Drug Development with ElMindAs Innovative Brain Network Activation Technology
2. Kendle Director of Global Safety and Pharmacovigilance, Drew Kilpatrick, PhD, Named One of Ten Notable People in R&D
3. Kendle Executive to Share Insights at World Pharma Trials Asia 2010
4. Kendle is First Global CRO to Achieve ISO 9001:2008 Certification in China Through Beijing Affiliate
5. Kendle Launches New Global Biostatistics Infrastructure
6. Kendle Receives Approval From Indian Government to Proceed With Development of Operations Center in Special Economic Zone
7. Kendle Appoints J. Michael Sprafka, MPH, PhD, Vice President, Kendle Consulting
8. Kendle Announces Details Regarding Third Quarter 2009 Earnings Conference Call and Webcast
9. Kendle Experts to Share Insights at the Regulatory Affairs Professionals Society Annual Conference and Exhibition
10. Kendle Experts to Present at the Drug Information Association 44th Annual Meeting
11. Regado Biosciences to Present at the 2010 Wells Fargo Healthcare Conference on June 24, 2010 in Boston, Massachusetts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... PHILADELPHIA , March 30, 2017  Lannett Company, ... the company voluntarily made a $25 million payment against ... $25 million payment, combined with the $75 million payment ... us approximately $5.5 million in annualized cash interest expense, ... executive officer of Lannett.  "Our business is solid and ...
(Date:3/29/2017)... Research and Markets has announced the addition of the ... (Insource IONM, Outsource IONM), By Region And Trend Analysis From ... ... Intraoperative Neuromonitoring (IONM) market is expected to reach USD 3.6 ... witness significant growth in the forecast period, which can be ...
(Date:3/29/2017)... NEW YORK , March 29, 2017 Global ... cross US$ 3 billion by 2021, growing at a CAGR ... containing iron prescribed by a doctor to treat anemia or ... the iron level in the body. However, in some cases, ... in the body and intravenous (IV) iron therapy comes into ...
Breaking Medicine Technology:
(Date:3/30/2017)... ... ... inventor and manicurist from Greet, S.C., wants to offer people a new way to care ... and healthy feet, so I know the importance of proper foot care," he said. "In ... FOOT-TRAN SYSTEM." , The FOOT-TRAN SYSTEM enables a user to clean and exfoliate the bottoms ...
(Date:3/30/2017)... ... 30, 2017 , ... This morning, more than 275 medical ... support for an independent Vaccine Safety Commission. Five of the signers of the ... hold a press conference at 9:00 AM Friday, March 31 at the ...
(Date:3/29/2017)... San Diego, CA (PRWEB) , ... March 29, 2017 , ... ... meningiomas(1,2), and up to 300,000 people each year develop other types of metastatic brain ... spread quickly throughout the brain(3). As efforts focus on finding more effective treatment options, ...
(Date:3/29/2017)... ... ... main cause of hay fever in the United States, with an estimated 95 percent of ... July each year; with the worst time for sufferers being June and July. , ... provide an effective defense against grass pollen; they are proven in independent studies to trap ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sublime Naturals and its ... Life" or "Wonder Spice", it has been used for thousands of years. , "The ... says Heshelow, author of " Turmeric: How to Use it For Your Wellness. Overcome ...
Breaking Medicine News(10 mins):